Evidence map›Paper›PMID 33175708›Full record

ArticleJournal of infection in developing countries2020

Cost Effectiveness of Sample Pooling to Test for SARS-CoV-2.

Baha Abdalhamid, Christopher Richard Bilder, Jodi Louise Garrett, Peter Charles Iwen

Abstract readLetter
In one paragraph

Article in Journal of infection in developing countries, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.Diagnostic microbiology and infectious disease · 2021
    Review
  11. Article
  12. Observational
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Baha AbdalhamidDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, United States. babdalhamid@unmc.edu.
Christopher Richard BilderDepartment of Statistics, University of Nebraska-Lincoln, Lincoln, NE, United States. bilder@unl.edu.
Jodi Louise GarrettClinical Laboratory, Nebraska Medicine, Omaha, NE, United States. JLGarrett@nebraskamed.com.
Peter Charles IwenDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, United States. piwen@unmc.edu.

Funding

Group testing for infectious disease detection: multiplex assays and back-end screeningR01AI121351 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI BILDER, CHRISTOPHER R · 2016 to 2025
$3.3M
NIAID NIH HHS R01 AI121351
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusClinical Laboratory TechniquesCoronavirus InfectionsCost-Benefit AnalysisCOVID-19COVID-19 TestingHumansMass ScreeningPandemicsPneumonia, ViralProof of Concept StudySARS-CoV-2Sample PoolingSARS-CoV-2savings

Identifiers

PMID33175708
PMCPMC7962623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.